Significant reduction of factor D and immunosuppressive complement fragment Ba by hemofiltration

Area of Science:

• Immunology
• Nephrology
• Biochemistry

Background:

• Factor D (FD) and complement fragment Ba influence immune response, particularly in renal failure.
• These high-molecular-weight substances (FD: 24,000 D, Ba: 33,000 D) are not removed by conventional hemodialysis.
• Their accumulation may impact the immunological status of patients with chronic or acute renal failure.

Purpose of the Study:

• To investigate the efficacy of hemofiltration (HF) in reducing plasma concentrations of FD and Ba.
• To determine if FD and Ba can be eliminated via hemofiltrate.
• To compare the effectiveness of convective (HF) versus diffusive (hemodialysis) blood purification for these substances.

Main Methods:

• Plasma levels of FD and Ba were measured before and after hemofiltration treatment.
• The presence of FD and Ba in the hemofiltrate was analyzed.
• Quantification of eliminated FD and Ba per treatment based on plasma levels and filtration volume.

Main Results:

• Hemofiltration significantly reduced plasma FD levels by 43.5% and Ba levels by 30.6%.
• Both FD and Ba were detected in the hemofiltrate, indicating their removal.
• Up to 75 mg of FD and 37 mg of Ba could be eliminated per HF treatment.

Conclusions:

• Chronic hemofiltration is a superior convective method for eliminating high-molecular-weight substances like FD and Ba compared to diffusive methods.
• The study demonstrates the potential of HF in managing immune components in renal failure patients.
• Further research is needed to ascertain if chronic HF leads to sustained improvements in immunological status.